Seattle, Washington, United States In 2009 was created WINGS, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Seattle. The venture was found in North America in United States.
The typical case for the fund is to invest in rounds with 2 participants. The meaningful sponsors for the fund in investment in the same round are W Fund. In the next rounds fund is usually obtained by W Fund, Trinity Ventures, SpringRock Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Software, Biotechnology. Among the various public portfolio startups of the fund, we may underline Cyrus Biotechnology Besides, a startup needs to be aged 1 and less years to get the investment from the fund.
This organization was formed by Tom Clement.
The common things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2015.
| Fund Name | Location |
| Andisa Capital | Gauteng, NA - South Africa, South Africa |
| APAGM | Canada, Montréal, Quebec |
| BTG | England, London, United Kingdom |
| Chance Technologies | Georgetown, Texas, United States |
| Envirotek | - |
| Shenzhen Capchem Technology | China, Guangdong, Shenzhen |
| VEGA corporation Japan | Fukuoka, Fukuoka Prefecture, Japan |
| Xizang Fengtai Touzi | - |
| Zhongtou8.cn | China, Hunan, Nanshan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Cyrus Biotechnology | $850K | 06 May 2015 | Seattle, Washington, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Cyrus Biotechnology | $850K | 06 May 2015 | Seattle, Washington, United States |
